ReviewEULAR rheumatology open2025
The concept of placebo/nocebo response and effect.
Review in EULAR rheumatology open, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
1 author.
Funding
No grant is acknowledged in the PubMed record.
Abstract
The placebo response is different from the placebo effect. Whereas the placebo response is the global response to a placebo, including spontaneous remission, regression to the mean, patients' and experimenters' biases, possible effects of cointerventions, as well as psychological factors, the placebo effect includes only the psychological factors, such as the patients' expectations and learning/conditioning. It is like the difference between drug response and drug effect: whereas the former is the global response to a drug, including all the factors described above, the latter represents the specific pharmacodynamic effect. Nocebo responses and nocebo effects go in the opposite direction; these consist of the experience of adverse events when a placebo is administered. The difference between response and effect is crucial for at least two reasons. First, clinical trials are aimed at identifying placebo responses, regardless of the mechanisms that are involved. Second, the identification of the real psychobiological placebo effect aims to understand the underlying mechanisms, that is, what is going on in the patient's brain when he receives a placebo treatment.
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.